Calgary, AB – January 25, 2020
In the last year, Canada’s National Association of Pharmacy Regulatory Authorities (NAPRA) published Model Standards for Pharmacy Compounding of Non-sterile Preparations and the companion Guidance Document for Pharmacy Compounding of Non-sterile Preparations. Navigating through these new requirements and strategizing their practical implementation can be challenging.
During this 8-hour live event, participants will be guided through the new 2018 NAPRA standards of practice with an emphasis on how to practically implement and apply these standards today. The framework of this program mirrors NAPRA’s model standards’ unique infrastructure:
- Regulatory framework
- Quality assurance program
- Risk management
- Verification program
- Personnel competency and compliance
- Property (facility, equipment, and technology) management
- Procedures in support of day-to-day operations
- Process development leading to approved master formulation records
- Master formulation record database management
- Compounding record and patient management
This program aims to take NAPRA’s standards of practice to the next level by teasing apart ambiguities and providing recommendations and justifications for the adoption of best practices, where applicable. The overarching goal of this program is to provide its audience with clear and concise practical tools that will enable them to achieve compliance with NAPRA’s standards of practice. Through interactive group discussion, participants will establish goals, place tasks on timelines, determine work task allocations, resource requirements, and master task schedules that address competency and compliance requirements. In doing so, participants will be guided through a smooth transition to a new standard of practice, while continuing to manage and oversee current compounding operations.
FOR PHARMACISTS & PHARMACY TECHNICIANS
Learning objectives for this program will be based on a combination of three types of objectives as outlined in the Canadian Council on Continuing Education in Pharmacy:
Knowledge Measurement Objectives
- Identify elements of the current regulatory framework for compounding in Canada as it applies to Federal, Provincial/Territorial jurisdictional law, and standards of practice.
- Describe quality assurance, risk management, and verification program requirements outlined in the Guidance Document for Pharmacy Compounding of Non-sterile Preparations.
- Identify policy and procedure requirements that reflect the current NAPRA model standards.
- Detail current requirements of master formulation and compounding records.
- Discuss approaches to ensure personnel safety, and the quality and safety of non-sterile preparations.
Reflective Assessment Objectives (integration of concepts and ideas)
- Apply and adapt standards of practice to best suit your compounding practice.
- Demonstrate the application and integration of a learned policy and procedure infrastructure into your practice.
- Differentiate competency assessments from compliance indicators.
- Integrate a best practice’s approach commensurate with the size, complexity, and risks associated specifically to your compounding practice.
Authentic Assessment Objectives (compounding practice performance-based)
- Develop a strategic action plan to manage the implementation of the new 2018 NAPRA standards of practice.
This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.
The live activity workbook is copyright © 2019 LP3 Network.
Please proceed to the St. Louis I & II meeting room for sign-in and registration.
QUINTON DIDYK, BSc, BS Pharm, RPEBC
Mr. Didyk graduated from the University of Manitoba Faculty of Pharmacy in 2002 and immediately went to work as a Pharmacy Services Specialist for the Western Canada division of a national pharmacy provider. Mr. Didyk gained early experience in community pharmacy practice, and in 2005 his career evolved into the ownership and management of community health services. He developed health centres in the Winnipeg area that provided primary and ancillary healthcare services all under one roof. These clinics were pioneers in establishing solid patient outcomes through the use of electronic medical records. His efforts were noted in 2006 when he received the Young Leader in Pharmacy award from the Manitoba Society of Pharmacists.
Mr. Didyk has been a facilitator for sterile and non-sterile compounding programs since 2008. His skills and expertise in compounding have made him nationally recognized as an expert in his field. He owns and operates the largest compounding-only facility in Manitoba that delivers specialized patient specific healthcare on a daily basis. In 2015, Mr. Didyk expanded his scope by becoming a surveyor for the Accreditation Commission for Health Care (ACHC).
|NEIL COHEN, BSc|
CE Program Developer
QUINTON DIDYK, BSc, BS Pharm, RPEBC
|This program is accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for Pharmacists and Pharmacy Technicians.|
|PHARMACIST CCCEP NUMBER||1463-2018-2617-L-P|
|PHARMACY TECHNICIAN CCCEP NUMBER||1463-2018-2618-L-T|
|RELEASE DATE||January 10, 2019|
|EXPIRATION DATE||January 10, 2021|
- Attend the live activity in full (sign-in and sign-out) and demonstrate satisfactory participation.
- Submit a completed evaluation form online.
- Complete a post live event online learner assessment within a two week period; minimum 70% passing grade required.
- When the aforementioned steps have been completed and approved; participants registered will receive a statement of completion by email.
CANCELLATION AND REFUND POLICY:
In the event that LP3 Network cancels a course, LP3 Network's sole liability shall be course repayment. In no event shall LP3 Network be responsible for any costs related to travel and/or accommodation. A written request must be sent to LP3 Network Inc. requesting ‘Cancellation without Transfer’ to an alternate live activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. There are no refunds, returns, or transfer requests upon purchase of a home study, digital work book, webinar, and eLearning modules. LP3 NETWORK INC. shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to LP3 NETWORK INC. in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, LP3 NETWORK INC. will not issue any refunds, only transfer to an alternate live activity event date.
The transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity date. Failure to submit the “Transfer Request” at least 14 days prior to the original live activity date will default to the “Cancellation and Refund Policy”. The transfer policy can only be applied one (1) time. Transfer to a new live activity date must be within the current calendar year. Failure to attend the new live activity will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to approval by LP3 Network based on the number of available seats within the selected live activity. There are no refunds, returns, or transfers upon purchase of the home study.